| | | | | | |
| | | | | | |
| | | | | | | | |
Cash and cash equivalents | | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
Accrued officer compensation | | | | | | | | |
| | | | | | | | |
Put premium on stock settled debt | | | | | | | | |
| | | | | | | | |
| | | | | | | | |
Loans payable, current portion | | | | | | | | |
Total Current Liabilities | | | | | | | | |
| | | | | | | | |
Loans payable, net of current portion | | | | | | | | |
| | | | | | | | |
| | | | | | | | |
Commitments and Contingencies (Note 13) | | | | | | | | |
| | | | | | | | |
| | | | | | | | |
Series A Preferred stock, 3,500,000 shares authorized, par value $0.01; 3,381,520 and 0 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively | | | | | | | | |
Series B Preferred stock, 10,000 shares authorized, par value $0.01; 5,000 and 0 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively | | | | | | | | |
Series C Preferred stock, 10,000,000 shares authorized, par value $0.01; 5,000,000 and 0 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively | | | | | | | | |
Series D Preferred stock, 125,000 shares authorized, par value $0.0001; 125,000 and 0 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively | | | | | | | | |
Series E Preferred stock to be issued | | | | | | | | |
Series F Preferred stock, 101 shares authorized, par value $0.0001; 101 and 0 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively | | | | | | | | |
Series G Preferred stock, 1,000,000 shares authorized, par value $0.0001; 1,000,000 and 0 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively | | | | | | | | |
Series AA Preferred stock, 10,000,000 shares authorized, par value $0.0001; 0 and 652,259 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively | | | | | | | | |
Series Super Preferred stock, 10,000,000 shares authorized, par value $0.0001; 0 and 500 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively | | | | | | | | |
Common stock 20,000,000,000 shares authorized, $0.0001 par value; 15,628,974,812 and 18,150,000 shares issued and outstanding, respectively at September 30, 2022 and December 31, 2021 | | | | | | | | |
Common stock to be issued, 2,550,000 and 0 shares as of September 30, 2022 and December 31, 2021, respectively | | | | | | | | |
Treasury stock, at cost – 2,917 shares and 0 shares as of September 30, 2022 and December 31, 2021, respectively | | | | | | | | |
Additional paid in capital | | | | | | | | |
| | | | | | | | |
Total Stockholders’ Deficit | | | | | | | | |
Total Liabilities and Stockholders’ Deficit | | | | | | | | |